Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2019-03-11 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于转让参股子公司和信健康股权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the transfer of equity in a subsidiary company and related parties. It details the transaction overview, parties involved, shareholding changes, pricing, contract terms, and the impact on the company. It includes board meeting resolutions and independent director opinions. There are no financial statements or comprehensive financial performance data presented, nor is it a transcript or presentation. The document is a formal disclosure of a corporate transaction (equity transfer) and related governance approvals. This fits the category of a Capital/Financing Update (CAP), as it concerns changes in the company's capital structure through equity transfer of a subsidiary stake.
2019-03-11 Chinese
第四届监事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. regarding the approval of a proposal to transfer equity in an associate company. It includes details about the meeting, voting results, and references to a related announcement on a regulatory disclosure website. The document is short (1124 characters) and primarily serves as an official announcement of a board decision rather than a full report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is not a report publication announcement since it contains substantive content about the board resolution and voting results. The best fitting category is 'Board/Management Information (MANG)' as it relates to a board meeting decision and management-level approval.
2019-03-11 Chinese
独立董事关于第四届董事会第十九次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the 19th meeting of the 4th board of directors of Guangzhou Yangpu Medical Technology Co., Ltd. It discusses approval of a transaction involving the transfer of equity in a subsidiary. The document references compliance with company law, stock exchange rules, and company articles, and includes signatures of independent directors. It is not a full annual or interim report, nor an earnings release or audit report. It is a formal board/management related announcement concerning board meeting decisions and opinions. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2019-03-11 Chinese
第四届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 19th meeting of the 4th Board of Directors of Guangzhou Yangpu Medical Technology Co., Ltd. It details decisions such as the approval of a proposal to transfer equity in a subsidiary and the scheduling of an extraordinary general meeting to consider these matters. The document includes voting results and references to related announcements on a regulatory disclosure website. It does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1537 characters), and it is not merely an announcement of a report but contains substantive board decisions. Therefore, the appropriate classification is MANG with high confidence.
2019-03-11 Chinese
关于收到医疗器械注册变更文件的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration change document issued by the National Medical Products Administration (国家药品监督管理局). It details the product name, registration certificate number, changes in product specifications, approval department, and approval date. The document also discusses the impact and risk related to this registration change. There is no financial data, no mention of financial results, no shareholder voting information, no management changes, no legal proceedings, no capital or financing updates, and no regulatory certifications. The document is a regulatory announcement about product registration changes, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive information about the registration change itself. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-03-07 Chinese
关于收到《中国证监会行政许可申请终止审查通知书》的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the receipt of a notice from the China Securities Regulatory Commission (CSRC) about the termination of the review of the company's administrative license application for a non-public stock issuance. It mentions the company's decision to terminate the non-public stock issuance and withdraw the application materials. The document is short (657 characters) and serves as a regulatory announcement about the status of a financing activity, specifically the termination of a non-public stock issuance application. This fits the category of Capital/Financing Update (CAP) as it relates to updates on company fundraising and capital structure changes.
2019-02-25 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.